TRIBTrinity Biotech plc
10.60USDMkt Cap: 8.62M $P/E: —3d ago
Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the …
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap8.62M $
Enterprise Value139.97M $
Revenue (TTM)43.78M $
Gross Profit16.89M $
Net Income (TTM)-37.38M $
Revenue/Share70.71 USD
Last Price10.60 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees287
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS8964383066
Valuation
P/E (Trailing)—
P/E (Forward)-10.24
PEG0.30
EV/EBITDA-16.98
EV/Revenue3.20
P/S0.20
P/B-0.09
EPS (TTM)-60.00
EPS (Forward)-1.03
52W Range
10.2933% of range11.24
52W High11.24 USD
52W Low10.29 USD
Profitability
Gross Margin38.57%
Oper. Margin-9.98%
EBITDA Margin-18.83%
Profit Margin-85.36%
ROE51.92%
ROA-35.54%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.93M $
CapEx (TTM)6.22M $
FCF Margin-25.57%
FCF Yield-129.90%
Net Debt132.85M $
Net Debt/EBITDA-16.12
Balance Sheet
Debt/Equity-1.92
Current Ratio0.25
Quick Ratio0.11
Book Value/Sh-115.4150 USD
Cash/Share7.612 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield1.19%
Payout Ratio0.00%
Ex-Div DateJun 5, 2015
Pay DateJul 1, 2015
Splits
Last Split1:30
Split DateJul 24, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.813.13K
Float530.97K
Insiders13.77%
Institutions4.07%
Short Interest
Short Ratio0.6d
Short % Float9.59%
Short % Out.2.54%
Shares Short17.14K
Short (prev mo.)47.25K
Technical
SMA 5012.63 (-16.1%)
SMA 20020.46 (-48.2%)
Beta0.99
S&P 52W Chg21.00%
Avg Vol (30d)8.10K
Avg Vol (10d)45.82K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—